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Clinical vignette 
A 38-year-old man presented with recurrent fever, night sweat, retrosternal pain and vomiting. 
Laboratory test failed to identify a viral or bacterial agent. The patient did not respond to antibiotics. 
Transoesophageal echocardiography showed pericardial effusion and no valvular vegetations. The 
patient was referred to fluoro-deoxy-glucose-positron emission tomography/computed tomography 
(FDG-PET/CT) to identify an infectious focus. Whole-body FDG-PET/CT was performed after fasting 
and one hour after intraveneous administration of 350 MBq FDG. Coronal PET image (Panel D) 
demonstrates increased uptake in the whole pericardium, pronounced on the right side (long arrows). 
PET/CT technique provides cross-sectional axial CT- (Panel A), PET- (Panel B) and fused PET/CT-
(Panel C) images. The pericardial layers were thickened and took up FDG. Between the pericardial 
layers effusion was visible. Additionally, small pleural effusion was detected on the right side (short 
arrows). Pericardial biopsy was performed. The histopatholgical examination showed fibrosis with 
chronic sclerosing and lymphoplasmacellular inflammation consistent with chronic sclerosing 
pericarditis (Panel E/Fig. 2). A specific etiological lesion (e.g. granulomas, rheumatoid nodules) could 
not be identified. Furthermore, no causing agent could be identified on specially stained histological 
sections, in microbiology or with PCR. A therapy with corticosteroids was not successful and 9 months 
after the biopsy a pericardectomy was necessary because of the pericardial constriction.  
Although the majority of patients imaged with FDG-PET/CT suffer from malignant diseases, this 
radionuclide is not tumorspecific. It has been proven experimentally that inflammatory cells also take 
up FDG. The most experience with FDG in infection and inflammation imaging exists in patients with 
fever of unknown origin and osteomyelitis. FDG-PET/(CT) has been used in the cardio-vascular area 
for imaging of large vessel vasculitis (Takayasu or giant cell arteriitis) and graft infections. Because 
there can be markedly physiological uptake of FDG in the heart, especially in the left ventricle 
myocardium, it is crucial to differentiate pathological FDG-uptake due to pericarditis from physiological 
uptake. That’s why patient preparation for imaging of inflammatory or infectious heart diseases with 
FDG differs from preparation for myocardial viability studies. In infection indications fasting for at least 
4 hours should guarantee energy supply of the myocardium by fatty acids. In FDG-viability studies the 
combination of glucose and insulin administration before FDG-injection leads to FDG-uptake by 
switching the energy supply from fatty acids to glucose. Our case demonstrates that it is possible to 
visualize an chronically active pericarditis with FDG-PET/CT. Of course, FDG-PET/CT should not be 
the first imaging tool for patients with the suspicion for pericarditis but in unclear cases it may help to 
proove the diagnosis, to show the extent of the disease, to exclude other infectious foci, to guide the 
biopsy and it might be useful for therapy response assessment.  
Figure 
Panel A axial low-dose CT image showing the thickened pericardial layers (long arrow) with pericardial 
effusion inbetween and pleural effusion (short arrow). 
Panel B corresponding axial PET image with increased FDG-uptake in the pericardium (arrow) 
Panel C fusion of corresponding CT and PET image illustrating that the increased FDG-uptake 
matches with the pericardium. 
Panel D coronal MIP (maximum intensity projection ) image with increased FDG-uptake in the 
pericardium (arrow). 
Panel E Hematoxylin-eosin stained histologic section (200x) showing fibrotic soft tissue with a chronic 
lympho-plasmacellular inflammatory infiltrate interspersed between thick collagenous bundles.  
